Recombinant Coxiella burnetii ATP synthase subunit delta (atpH)

What is Coxiella burnetii ATP synthase subunit delta (atpH) and what are its key structural features?

Coxiella burnetii ATP synthase subunit delta (atpH) is a component of the F-type ATP synthase complex in C. burnetii, the causative agent of Q fever. The full-length protein consists of 185 amino acids with the sequence beginning with MALHLTLARP and ending with KLTRLAENLKG. It functions as part of the F1 sector of ATP synthase, which is critical for energy metabolism in this intracellular pathogen. Structurally, the protein contains regions that facilitate its interaction with other subunits of the ATP synthase complex to enable proper assembly and function of the enzyme complex that catalyzes ATP synthesis .

How does the ATP synthase complex contribute to Coxiella burnetii pathogenesis?

The ATP synthase complex plays a crucial role in C. burnetii pathogenesis by enabling energy production under the acidic conditions of the parasitophorous vacuole. C. burnetii shows remarkable ability to regulate its ATP pools in response to environmental conditions, with ATP levels being maintained at approximately 0.7 nmol of ATP per mg of dry weight over 96 hours at pH 4.5 in the presence of appropriate substrates like glutamate. This energy regulation contributes significantly to the pathogen's ability to survive in harsh environments and subsequently reactivate upon entry into the phagolysosome where replication occurs. The stability of the ATP pool directly correlates with bacterial viability, with significant viability loss observed when ATP levels drop below certain thresholds .

How does the expression and purification of recombinant Coxiella burnetii atpH differ from other bacterial recombinant proteins?

Recombinant C. burnetii atpH is typically expressed in E. coli expression systems, similar to many bacterial proteins, but requires specific considerations due to the unique properties of C. burnetii proteins. The protein can be purified to >85% purity using SDS-PAGE, and typically requires careful handling during the purification process. Unlike some other recombinant proteins, C. burnetii atpH may be particularly sensitive to repeated freeze-thaw cycles, which should be avoided by storing working aliquots at 4°C for up to one week. For long-term storage, the addition of 5-50% glycerol (with 50% being typical) and storage at -20°C or -80°C is recommended to maintain structural integrity and functionality .

What are the optimal storage and handling conditions for maintaining recombinant Coxiella burnetii atpH stability?

The optimal storage conditions for recombinant C. burnetii atpH include initial storage at -20°C, with extended storage at either -20°C or -80°C. When preparing the protein for experimental use, it should be briefly centrifuged before opening to ensure contents are at the bottom of the container. Reconstitution should be performed in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL. For long-term stability, adding glycerol to a final concentration of 5-50% (with 50% being standard) is recommended before aliquoting and storing at -20°C/-80°C. It's crucial to avoid repeated freeze-thaw cycles as these can compromise protein integrity. Working aliquots should be stored at 4°C and used within one week to maintain optimal activity. Under these conditions, the shelf life of the liquid form is typically around 6 months, while the lyophilized form can remain stable for approximately 12 months .

What experimental approaches can be used to study the functional activity of recombinant Coxiella burnetii atpH?

To study the functional activity of recombinant C. burnetii atpH, researchers can employ multiple complementary approaches:

• ATP synthesis/hydrolysis assays: Measuring ATP production or consumption using luminescent ATP detection assays to quantify enzymatic activity.

• Reconstitution experiments: Incorporating the recombinant protein into liposomes or nanodiscs to study its function in a membrane-like environment, similar to studies conducted on C. burnetii's ability to couple oxidation of metabolic substrates to ATP synthesis in axenic reaction buffers .

• pH-dependent activity assays: Since C. burnetii demonstrates optimal metabolism at pH 4.5, assessing atpH functionality across different pH conditions (particularly comparing pH 4.5 and pH 7.0) to understand its role in the pathogen's adaptation to acidic environments .

• Protein-protein interaction studies: Using co-immunoprecipitation or pull-down assays to identify interactions between atpH and other subunits of the ATP synthase complex or potential regulatory proteins.

• Inhibitor studies: Evaluating the effects of electron transport or oxidative phosphorylation inhibitors on ATP synthesis to confirm that ATP pool stability is due to endogenous synthesis coupled to substrate oxidation .

What controls and validation steps are essential when working with recombinant Coxiella burnetii atpH in experimental settings?

When working with recombinant C. burnetii atpH, the following controls and validation steps are essential:

• Protein quality verification: Confirm protein purity (>85% by SDS-PAGE), integrity (by Western blot), and proper folding (using circular dichroism) before experimental use .

• Functional validation: Verify that the recombinant protein maintains proper ATP synthase activity through enzymatic assays comparing wild-type to inactive mutants.

• Negative controls: Include heat-inactivated protein samples to establish baseline measurements in functional assays.

• System-specific controls: When studying atpH in the context of ATP production, include controls with inhibitors of electron transport or oxidative phosphorylation to confirm that observed ATP synthesis is specifically linked to the activity of the ATP synthase complex .

• Substrate specificity controls: Compare activity with different metabolic substrates (pyruvate, succinate, glutamate) since C. burnetii demonstrates differential ATP production depending on substrate availability .

• pH controls: Include parallel experiments at both pH 4.5 (optimal for C. burnetii metabolism) and pH 7.0 to account for pH-dependent effects on protein function and stability .

• Tag interference assessment: If the recombinant protein contains tags, perform parallel experiments with tag-cleaved protein to ensure the tag does not interfere with function .

How does Coxiella burnetii ATP synthase activity contribute to the pathogen's unusual ability to thrive in acidic environments?

C. burnetii's ATP synthase activity is integral to its remarkable adaptation to acidic environments. At pH 4.5, which represents the optimal pH for C. burnetii metabolism, the pathogen efficiently couples the oxidation of specific substrates (particularly glutamate) to ATP synthesis. This capability allows C. burnetii to maintain its ATP pool at approximately 0.7 nmol of ATP per mg of dry weight over extended periods (96 hours) in acidic conditions that would be detrimental to most bacteria. The ATP synthase complex, of which atpH is a crucial component, enables this adaptation by functioning optimally in acidic environments, effectively converting the proton gradient across the bacterial membrane into ATP production. This specialized adaptation is essential for C. burnetii's survival within the acidic phagolysosome of host cells where it establishes its replicative niche. Additionally, the pathogen demonstrates a sophisticated ability to regulate its endogenous ATP levels in response to both substrate availability and environmental pH, conserving metabolic energy in neutral or alkaline environments and activating metabolism upon encountering the acidic conditions of the phagolysosome .

What is the relationship between ATP synthase function and other virulence mechanisms in Coxiella burnetii?

The ATP synthase complex in C. burnetii serves as a fundamental metabolic engine that supports various virulence mechanisms. While not directly involved in host cell manipulation like some dedicated effector proteins, ATP synthase provides the energy currency necessary for multiple virulence activities:

• Support for T4SS effector protein function: C. burnetii depends on a functional Type IV Secretion System (T4SS) to inject approximately 150 virulence factors into host cells. These effector proteins, like AnkG (CBU0781), require substantial energy for their synthesis, folding, and secretion. AnkG specifically interacts with host cell components to manipulate transcription and prevent apoptosis, activities that would not be possible without adequate ATP supply .

• Energy for survival under stress: ATP generated by the ATP synthase complex enables C. burnetii to resist environmental stresses and host defense mechanisms, contributing to its remarkable environmental persistence.

• Metabolic adaptation: The ability to regulate ATP levels in response to environment allows C. burnetii to rapidly adapt to changing conditions within the host, transitioning between dormant-like states in neutral/alkaline environments and active metabolism in acidic conditions .

• Support for bifunctional enzyme activities: Recently identified enzymes like CbFic2 perform sophisticated biochemical functions including both AMPylation and deAMPylation of host proteins. These ATP-dependent activities require a stable supply of ATP, which is maintained by the ATP synthase complex .

These interconnected relationships highlight how ATP synthase activity serves as a fundamental requirement for C. burnetii's broader virulence mechanisms and ability to establish a persistent infection.

What unique adaptations are observed in Coxiella burnetii atpH compared to homologous proteins in other bacteria?

While the search results don't provide specific information comparing C. burnetii atpH with homologous proteins in other bacteria, we can infer several likely adaptations based on C. burnetii's unique lifestyle and the available information:

• Acid stability and function: Given C. burnetii's adaptation to thrive at pH 4.5, its atpH likely contains structural modifications that enhance stability and function in acidic environments compared to homologous proteins from neutralophilic bacteria.

• Substrate preference adaptations: C. burnetii demonstrates a strong preference for glutamate as a substrate for maintaining ATP levels, suggesting possible adaptations in the ATP synthase complex that optimize efficiency with this particular substrate .

• Regulatory mechanisms: C. burnetii shows sophisticated regulation of ATP levels in response to both pH and substrate availability, suggesting potential unique regulatory features in its ATP synthase components, possibly including atpH .

• Integration with specialized pathogen mechanisms: As part of a pathogen with a T4SS and numerous effector proteins, C. burnetii's ATP synthase components likely feature adaptations that support energy requirements for these specialized virulence mechanisms .

A comprehensive comparative analysis of C. burnetii atpH with homologous proteins would require additional experimental data, including structural studies and functional comparisons across species.

How can recombinant Coxiella burnetii atpH be utilized in vaccine development strategies against Q fever?

Recombinant C. burnetii atpH represents a potential candidate for inclusion in subunit vaccine formulations against Q fever. Previous attempts at developing Q fever vaccines using recombinant C. burnetii proteins have shown mixed results. A study testing eight recombinant C. burnetii proteins (Omp, Pmm, HspB, Fbp, Orf410, Crc, CbMip, and MucZ) found that while most were antigenic in mice, they failed to provide protection in challenge infections. Only the licensed Q-Vax vaccine demonstrated protective effects .

For utilizing atpH in vaccine development, researchers should consider the following approaches:

• Antigenicity screening: Determine the immunogenicity of recombinant atpH in animal models, assessing both humoral and cell-mediated immune responses.

• Epitope mapping: Identify specific antigenic epitopes within atpH that might elicit protective immune responses, potentially focusing on conserved regions essential for function.

• Combination strategies: Test atpH in combination with other immunogenic C. burnetii proteins, potentially including those involved in virulence but avoiding those that previously failed to provide protection .

• Adjuvant optimization: Explore various adjuvant formulations to enhance the immunogenicity of recombinant atpH, as adjuvant selection has been shown to significantly impact vaccine efficacy.

• Delivery system development: Investigate novel delivery systems such as nanoparticles or virus-like particles that might improve the presentation of atpH to the immune system.

• Challenge models: Utilize appropriate animal models for challenge infections to assess protective efficacy, carefully controlling for factors that might have contributed to previous failures .

Given the previous unsuccessful attempts with other recombinant proteins, researchers should approach atpH-based vaccine development with careful attention to factors that might enhance its potential as a protective antigen.

What techniques can be employed to study the interactions between Coxiella burnetii atpH and host cell components during infection?

To study interactions between C. burnetii atpH and host cell components during infection, researchers can employ multiple complementary techniques:

• Proximity-based labeling approaches: Techniques such as BioID or APEX2 can be used to identify proteins that come into close proximity with atpH during infection by fusing these enzyme tags to atpH and identifying biotinylated proteins.

• Co-immunoprecipitation and pull-down assays: These can be performed using antibodies against atpH or epitope-tagged versions of the protein to identify host proteins that physically interact with it, similar to the approaches used to identify interactions between the C. burnetii effector protein AnkG and host components .

• Yeast two-hybrid screening: This can be used as an initial approach to identify potential protein-protein interactions between atpH and host cell proteins.

• Fluorescence microscopy: Immunofluorescence or live-cell imaging using fluorescently tagged atpH can reveal its localization within infected cells and potential co-localization with host structures.

• Cryo-electron microscopy: This can provide structural insights into complexes formed between atpH and host proteins.

• Transcriptomics and proteomics: These approaches can identify host cellular responses to atpH expression or to C. burnetii mutants with altered atpH function.

• CRISPR-Cas9 screening: This can identify host factors that influence atpH function or that are required for any effects atpH might have on host cells.

• Functional assays: Based on the ATP synthase function of atpH, assays measuring changes in host cell energy metabolism during infection could reveal functional interactions.

Each of these approaches provides different and complementary information about potential interactions, and combining multiple methods would provide the most comprehensive understanding.

How might structural analysis of Coxiella burnetii atpH inform the development of targeted antimicrobial strategies?

Structural analysis of C. burnetii atpH could significantly advance the development of targeted antimicrobial strategies through several avenues:

• Identification of unique structural features: Detailed structural characterization through techniques like X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy could reveal unique structural elements of C. burnetii atpH that differ from host ATP synthase components or homologous proteins in other bacteria.

• Structure-based drug design: Once unique structural features are identified, computational approaches can be used to design small molecule inhibitors that specifically target these regions, potentially disrupting the function of C. burnetii ATP synthase without affecting host proteins.

• Binding pocket analysis: Identifying substrate binding pockets or interaction surfaces unique to C. burnetii atpH could provide targets for small molecule inhibitors that would selectively disrupt ATP synthase function in this pathogen.

• Conformational dynamics: Understanding the conformational changes that occur during the catalytic cycle of ATP synthase in C. burnetii could reveal potential points of intervention where the enzyme is particularly vulnerable to inhibition.

• Interface targeting: Analysis of the interfaces between atpH and other ATP synthase subunits could identify opportunities for disrupting complex assembly, which would be particularly effective if these interfaces differ from those in host cells or non-pathogenic bacteria.

• Allosteric site identification: Structural analysis might reveal allosteric sites unique to C. burnetii atpH that could be targeted to modulate enzyme function indirectly, potentially offering greater selectivity.

• Peptide mimetic development: Structural insights could guide the design of peptide mimetics that interfere with critical protein-protein interactions involving atpH.

Given C. burnetii's unique adaptation to acidic environments and its critical dependence on ATP synthesis for survival in these conditions, targeting the ATP synthase complex through structure-guided approaches represents a promising strategy for developing selective antimicrobials against this challenging pathogen .

How does the function of ATP synthase compare with other energy-related enzymes in Coxiella burnetii's adaptation to intracellular life?

The ATP synthase complex, including the atpH subunit, plays a central role in C. burnetii's energy metabolism, but functions as part of an integrated network of energy-related enzymes that collectively enable adaptation to intracellular life:

• Comparative importance in acid adaptation: While many bacterial pathogens struggle in acidic environments, C. burnetii's ATP synthase functions optimally at pH 4.5, suggesting unique adaptations compared to other energy-generating systems. This acidophilic functionality is particularly crucial because C. burnetii replicates within acidified phagolysosomes .

• Substrate utilization network: C. burnetii demonstrates variable efficiency in utilizing different substrates for ATP generation, with glutamate, pyruvate, and succinate being preferred. This suggests a specialized metabolic network that channels specific substrates towards ATP synthesis, with glutamate oxidation resulting in the greatest stability of the ATP pool over extended periods .

• Integration with electron transport: The ATP synthase functions downstream of electron transport components, as evidenced by the depression of ATP levels in the presence of electron transport inhibitors. This highlights the integrated nature of C. burnetii's energy production systems .

• Relationship with adenylate energy charge regulation: During glutamate oxidation, C. burnetii's adenylate energy charge increases from 0.57 to 0.73, with a concomitant rise in the total adenylate pool size, indicating sophisticated regulation of the balance between ATP, ADP, and AMP pools .

• Support for specialized pathogen functions: Unlike many housekeeping enzymes, C. burnetii's ATP synthase indirectly supports specialized pathogen functions by providing energy for systems like the T4SS, which delivers effector proteins into host cells. Some of these effectors, like CbFic2, perform AMPylation reactions that require ATP as a substrate, creating a functional link between ATP synthesis and virulence mechanisms .

This integrated perspective highlights how ATP synthase functions within a broader network of metabolic enzymes that collectively enable C. burnetii's unique lifestyle as an intracellular pathogen adapted to acidic conditions.

What are the methodological challenges in studying interactions between recombinant Coxiella burnetii proteins and host cell targets?

Studying interactions between recombinant C. burnetii proteins and host cell targets presents several methodological challenges:

• Native conformation maintenance: Ensuring that recombinantly expressed C. burnetii proteins maintain their native conformation is challenging. The expression and purification process can affect protein folding, potentially altering interaction capabilities. This is particularly relevant for atpH, which normally functions as part of a multi-subunit complex .

• Acidic environment replication: C. burnetii naturally functions in the acidic environment of the phagolysosome (pH ~4.5), but many standard protein-protein interaction assays are optimized for neutral pH. Creating experimental conditions that reflect this acidic environment while maintaining the stability of host proteins presents significant technical challenges .

• Temporal dynamics of interactions: During infection, interactions between bacterial and host proteins likely occur in a temporally regulated manner. Capturing these dynamics with recombinant proteins outside the context of infection is methodologically challenging.

• Post-translational modifications: Recombinant proteins expressed in E. coli may lack post-translational modifications that occur in C. burnetii during infection and could be important for host interactions.

• Multi-protein complexes: Some C. burnetii proteins, like atpH, function as part of larger complexes. Studying individual recombinant proteins may not capture interactions that depend on these complex formations.

• Subcellular localization factors: The subcellular localization of C. burnetii proteins during infection may be critical for determining their interaction partners. Recombinant protein studies may miss interactions that depend on proper localization.

• Low-affinity or transient interactions: Some biologically relevant interactions may be of low affinity or transient nature, making them difficult to detect using standard biochemical approaches. This has been observed with other C. burnetii proteins like AnkG, which forms complexes with host proteins through interactions that may include salt bridges .

• Host cell heterogeneity: Different host cell types may express varying levels of potential interaction partners, necessitating careful selection of cell types for interaction studies.

Addressing these challenges requires combining multiple complementary approaches and carefully designing experiments that account for the unique biology of C. burnetii.

What emerging technologies might advance our understanding of Coxiella burnetii ATP synthase function in the context of host-pathogen interactions?

Several emerging technologies hold promise for advancing our understanding of C. burnetii ATP synthase function in host-pathogen interactions:

• Cryo-electron tomography: This technique enables visualization of macromolecular complexes in their native cellular environment at near-atomic resolution. Applied to infected cells, it could reveal the structure and organization of C. burnetii ATP synthase in the context of the bacterial cell membrane during infection.

• Single-cell metabolomics: Emerging single-cell metabolomic approaches could track ATP production and energy metabolism in individual bacteria within infected cells, providing insights into heterogeneity of ATP synthase function during infection.

• Genome-wide CRISPR screens: These could identify host factors that influence C. burnetii ATP synthase function or that are affected by ATP synthase activity, revealing unexpected connections between energy metabolism and host-pathogen interactions.

• Protein-protein interaction mapping in situ: Techniques like proximity labeling combined with mass spectrometry (BioID, APEX) performed in infected cells could map the protein interaction network of ATP synthase components, including atpH, during actual infection.

• Nanobody-based probes: Developing nanobodies against specific conformational states of ATP synthase components could allow tracking of enzyme activity states during infection.

• Real-time ATP imaging in living cells: Genetically encoded fluorescent sensors for ATP could be used to visualize ATP dynamics in both the pathogen and host cells during infection.

• Artificial intelligence for structure prediction: Tools like AlphaFold2 could predict structures of ATP synthase components and their complexes, generating hypotheses about function and interactions that can be experimentally tested.

• Microfluidic infection models: These could provide precise control over the infection microenvironment, allowing manipulation of factors like pH and nutrient availability while monitoring ATP synthase function.

• Integrative multi-omics approaches: Combining transcriptomics, proteomics, and metabolomics data could provide a systems-level understanding of how ATP synthase function integrates with broader metabolic networks during infection.

These technologies, especially when used in combination, have the potential to transform our understanding of how C. burnetii ATP synthase contributes to pathogenesis and host-pathogen interactions at a fundamental level.